GAMMA Investing’s Beam Therapeutics BEAM Stock Holding History

GAMMA Investing’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$32.8K	Buy	1,342 +367	+38%	+$10.2K	﹤0.01%	2631
2026 Q2	$33.5K	Sell	975 -144	-13%	-$4.35K	﹤0.01%	2555
2026 Q1	$26.7K	Buy	1,119 +533	+91%	+$14.8K	﹤0.01%	2566
2025 Q4	$16.2K	Buy	586 +325	+125%	+$8.29K	﹤0.01%	2725
2025 Q3	$6.33K	Sell	261 -434	-62%	-$8.63K	﹤0.01%	3083
2025 Q2	$11.8K	Sell	695 -1,209	-63%	-$21.1K	﹤0.01%	2727
2025 Q1	$37.2K	Sell	1,904 -3,818	-67%	-$100K	﹤0.01%	2002
2024 Q4	$142K	Buy	5,722 +1,102	+24%	+$28.1K	0.01%	883
2024 Q3	$113K	Buy	4,620 +544	+13%	+$14.1K	0.01%	916
2024 Q2	$95.5K	Buy	4,076 +3,691	+959%	+$90.7K	0.01%	801
2024 Q1	$12.7K	Buy	385 +153	+66%	+$4.77K	﹤0.01%	1923
2023 Q4	$5.66K	Buy	+232	New	+$5.76K	﹤0.01%	2179

Other funds holding BEAM

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GAMMA Investing's BEAM Position: Q3 2026 in Review

GAMMA Investing increased its Beam Therapeutics (BEAM) stake by 38% in Q3 2026, buying an estimated $10.2K and bringing the position to 1,342 shares worth $32.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2631.

GAMMA Investing first reported a position in BEAM in Q4 2023 and has held it in 12 quarters since. The position peaked at $142K in Q4 2024. 4 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.

GAMMA Investing held 1,342 shares of Beam Therapeutics worth $32.8K as of Q3 2026.
GAMMA Investing bought 367 Beam Therapeutics shares in Q3 2026, an estimated $10.2K.
Beam Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2631 holding.
GAMMA Investing first reported a position in Beam Therapeutics in Q4 2023 and has held it in 12 quarters since.
GAMMA Investing's Beam Therapeutics position peaked at $142K in Q4 2024.
4 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.